Evgeny Krupitsky

Summary

Publications

  1. doi Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute and St Petersburg State Pavlov Medical University, Bekhtereva Street 3, St Petersburg, Russian Federation
    Addiction 108:1628-37. 2013
  2. pmc Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial
    Wendee M Wechsberg
    RTI International, Research Triangle Park, NC, USA
    Subst Abuse Treat Prev Policy 7:1. 2012
  3. doi Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Lancet 377:1506-13. 2011
  4. pmc Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia
    Evgeny Krupitsky
    St Petersburg State Pavlov Medical University, St Petersburg, Russia St Petersburg Bekhterev Research Psychoneurological Institute, St Petersburg, Russia
    Drug Alcohol Depend 132:674-80. 2013
  5. pmc Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence
    Evgeny Krupitsky
    Department of Pharmacology, St Petersburg Pavlov State Medical University, St Petersburg, Russia
    Arch Gen Psychiatry 69:973-81. 2012
  6. pmc Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available
    Evgeny Krupitsky
    Department of Addictions, St Petersburg Bekhterev Psychoneurological Research Institute, St Petersburg, Russia
    Curr Psychiatry Rep 12:448-53. 2010

Collaborators

Detail Information

Publications6

  1. doi Injectable extended-release naltrexone (XR-NTX) for opioid dependence: long-term safety and effectiveness
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute and St Petersburg State Pavlov Medical University, Bekhtereva Street 3, St Petersburg, Russian Federation
    Addiction 108:1628-37. 2013
    ..To describe drug use and safety with intramuscular injectable extended-release naltrexone (XR-NTX) in opioid dependence during a 1-year open-label extension phase...
  2. pmc Double jeopardy--drug and sex risks among Russian women who inject drugs: initial feasibility and efficacy results of a small randomized controlled trial
    Wendee M Wechsberg
    RTI International, Research Triangle Park, NC, USA
    Subst Abuse Treat Prev Policy 7:1. 2012
    ....
  3. doi Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
    Evgeny Krupitsky
    Bekhterev Research Psychoneurological Institute, St Petersburg State Pavlov Medical University, St Petersburg, Russia
    Lancet 377:1506-13. 2011
    ....
  4. pmc Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia
    Evgeny Krupitsky
    St Petersburg State Pavlov Medical University, St Petersburg, Russia St Petersburg Bekhterev Research Psychoneurological Institute, St Petersburg, Russia
    Drug Alcohol Depend 132:674-80. 2013
    ..Stress is a key precipitant to discontinuing naltrexone and relapsing to opiate abuse. Alpha-2 adrenergic agonists like guanfacine may reduce stress induced craving and have reduced opiate relapse in small clinical trials...
  5. pmc Randomized trial of long-acting sustained-release naltrexone implant vs oral naltrexone or placebo for preventing relapse to opioid dependence
    Evgeny Krupitsky
    Department of Pharmacology, St Petersburg Pavlov State Medical University, St Petersburg, Russia
    Arch Gen Psychiatry 69:973-81. 2012
    ..More patients in the NI+OP than in the other groups develop wound infections or local irritation, but none are serious and all resolve with treatment. TRIAL REGISTRATION clinicaltrials.gov Identifier: NCT00678418...
  6. pmc Use of naltrexone to treat opioid addiction in a country in which methadone and buprenorphine are not available
    Evgeny Krupitsky
    Department of Addictions, St Petersburg Bekhterev Psychoneurological Research Institute, St Petersburg, Russia
    Curr Psychiatry Rep 12:448-53. 2010
    ..This article summarizes the results of studies conducted in Russia during the past 10 years that demonstrate these points...